Beatrice Setnik
About
Beatrice Setnik is a scholar working on Public Health, Environmental and Occupational Health, Anesthesiology and Pain Medicine and Physiology.
According to data from OpenAlex, Beatrice Setnik has authored 57 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Public Health, Environmental and Occupational Health, 34 papers in Anesthesiology and Pain Medicine and 13 papers in Physiology. Recurrent topics in Beatrice Setnik's work include Opioid Use Disorder Treatment (41 papers), Pain Management and Opioid Use (34 papers) and Pain Mechanisms and Treatments (11 papers). Beatrice Setnik is often cited by papers focused on Opioid Use Disorder Treatment (41 papers), Pain Management and Opioid Use (34 papers) and Pain Mechanisms and Treatments (11 papers). Beatrice Setnik collaborates with scholars based in United States, Canada and United Kingdom. Beatrice Setnik's co-authors include Kenneth W. Sommerville, Lynn R. Webster, Edward M. Sellers, Naama Levy‐Cooperman, Carl L. Roland, Joseph Stauffer, Kerri A. Schoedel, Franklin K. Johnson, Veeraindar Goli and Glenn C. Pixton and has published in prestigious journals such as Pain, International Journal of Pharmaceutics and SLEEP.
In The Last Decade
Beatrice Setnik
57 papers receiving 677 citations
Peers
Beatrice Setnik
Naama Levy‐Cooperman United States
Jeanne M. Manubay United States
Shanthi Mogali United States
Ilse Van Hove United States
Anne Roussin France
Shanna Babalonis United States
Trond Oskar Aamo Norway
Carmen Walter Germany
Hans Bijl Netherlands
Elmer Yu United States
Citations per year, relative to Beatrice Setnik Beatrice Setnik (= 1×)
peers
Naama Levy‐Cooperman
Countries citing papers authored by Beatrice Setnik
Since
Specialization
Citations
This map shows the geographic impact of Beatrice Setnik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beatrice Setnik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beatrice Setnik more than expected).
Fields of papers citing papers by Beatrice Setnik
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Beatrice Setnik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beatrice Setnik. The network helps show where Beatrice Setnik may publish in the future.
Co-authorship network of co-authors of Beatrice Setnik
This figure shows the co-authorship network connecting the top 25 collaborators of Beatrice Setnik. A scholar is included among the top collaborators of Beatrice Setnik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beatrice Setnik. Beatrice Setnik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Reissig, Chad J., Beatrice Setnik, Denise Milovan, et al.. (2025). A pilot, Placebo controlled, dose-Finding, Pharmacodynamic and Pharmacokinetic Study of Orally Administered Botanical Kratom in non-Dependent, Recreational Polydrug Users with Opioid Experience under Fed Conditions.. Drug and Alcohol Dependence. 267. 111659–111659.
2.
Moline, Margaret, Shoji Asakura, Ishani Landry, et al.. (2023). The abuse potential of lemborexant, a dual orexin receptor antagonist, according to the 8 factors of the Controlled Substances Act. Psychopharmacology. 240(4). 699–711.
3.
Pathak, Sanjeev, Bradley Vince, Debra Kelsh, et al.. (2018). Abuse Potential of Buprenorphine/Samidorphan Combination Compared to Buprenorphine and Placebo: A Phase 1 Randomized Controlled Trial. The Journal of Clinical Pharmacology. 59(2). 206–217.
4.
Pathak, Sanjeev, Bradley Vince, Debra Kelsh, et al.. (2018). Abuse Potential of Samidorphan: A Phase I, Oxycodone‐, Pentazocine‐, Naltrexone‐, and Placebo‐Controlled Study. The Journal of Clinical Pharmacology. 59(2). 218–228.
5.
Setnik, Beatrice, Carl L. Roland, Alexandra I. Barsdorf, Anne Brooks, & Karin S. Coyne. (2017). The content validation of the Self-Reported Misuse, Abuse and Diversion of Prescription Opioids (SR-MAD) instrument for use in patients with acute or chronic pain. Current Medical Research and Opinion. 33(6). 1067–1076.
6.
Smith, Shannon M., Judith K. Jones, Nathaniel P. Katz, et al.. (2017). Measures That Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: ACTTION Critique and Recommended Considerations. Journal of Pain. 18(11). 1287–1294.
7.
Setnik, Beatrice, Kerri A. Schoedel, Naama Levy‐Cooperman, et al.. (2017). Evaluating the abuse potential of opioids and abuse-deterrent opioid formulations: A review of clinical study methodology. Journal of Opioid Management. 13(6). 485–523.
8.
Setnik, Beatrice, et al.. (2017). Intranasal abuse potential of an abuse-deterrent oxycodone formulation compared to oxycodone immediate release and placebo in nondependent, recreational opioid users. Journal of Opioid Management. 13(6). 449–464.
9.
Setnik, Beatrice & Edward J. Cone. (2016). Establishing “abuse-deterrence equivalence” for generic abuse-deterrent opioid formulations: A proposed development framework. Journal of Opioid Management. 12(2). 96–100.
10.
Setnik, Beatrice, Carl L. Roland, Veeraindar Goli, et al.. (2015). Self-reports of prescription opioid abuse and diversion among recreational opioid users in a Canadian and a United States city. Journal of Opioid Management. 11(6). 463–473.
11.
Setnik, Beatrice, et al.. (2015). A multicenter, primary-care-based, open-label study to assess the success of converting opioid-experienced patients with chronic moderate-to-severe pain to morphine sulfate and naltrexone hydrochloride extended-release capsules using a standardized conversion guide. Journal of Pain Research. 8. 347–347.
12.
Setnik, Beatrice, Candace Bramson, Almasa Bass, et al.. (2015). Intranasal administration of crushed ALO‐02 (extended‐release oxycodone with sequestered naltrexone): A randomized, controlled abuse‐potential study in nondependent recreational opioid users. The Journal of Clinical Pharmacology. 55(12). 1351–1361.
13.
Arora, Samir, Beatrice Setnik, Paul Meisner, et al.. (2014). A multicenter, 12-month, open-label, single-arm safety study of oxycodone-hydrochloride/naltrexone-hydrochloride extended-release capsules (ALO-02) in patients with moderate-to-severe chronic noncancer pain. Journal of Opioid Management. 10(6). 423–436.
14.
Setnik, Beatrice, et al.. (2014). Content validity of the SR-MAD Rx opioids instrument for use in patients with acute or chronic pain. Value in Health. 17(3). A220–A220.
15.
Setnik, Beatrice, Carl L. Roland, Veeraindar Goli, Kenneth W. Sommerville, & Lynn R. Webster. (2013). A clinical trial to determine if corelease of morphine and naltrexone from crushed extended-release capsules induces withdrawal in opioid-dependent patients: A descriptive analysis of six patients. Journal of Opioid Management. 9(2). 139–150.
16.
Setnik, Beatrice, et al.. (2013). Assessing the Subjective and Physiological Effects of Intranasally Administered Crushed Extended‐Release Morphine Formulations with and without a Sequestered Naltrexone Core in Recreational Opioid Users. Pain Research and Management. 18(4). e55–62.
17.
Roland, Carl L., Beatrice Setnik, Jody M. Cleveland, & David A. Brown. (2011). Clinical Outcomes during Opioid Titration following Initiation with or Conversion to Remoxy®, an Extended-Release Formulation of Oxycodone. Postgraduate Medicine. 123(4). 148–159.
18.
Setnik, Beatrice, et al.. (2008). Ethanol effects on drug release from Verapamil Meltrex®, an innovative melt extruded formulation. International Journal of Pharmaceutics. 368(1-2). 72–75.
19.
Setnik, Beatrice & José N. Nóbrega. (2004). Long-chain acyl-CoenzymeA synthetase-2 mRNA: increased cerebral cortex expression in an animal model of depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 28(3). 577–582.
20.
Setnik, Beatrice, et al.. (2003). Increased homocysteine levels associated with sex and stress in the learned helplessness model of depression. Pharmacology Biochemistry and Behavior. 77(1). 155–161.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Naama Levy‐Cooperman Breakdown of academic impact, for papers by Jeanne M. Manubay Breakdown of academic impact, for papers by Shanthi Mogali Breakdown of academic impact, for papers by Ilse Van Hove Breakdown of academic impact, for papers by Anne Roussin Breakdown of academic impact, for papers by Shanna Babalonis Breakdown of academic impact, for papers by Trond Oskar Aamo Breakdown of academic impact, for papers by Carmen Walter Breakdown of academic impact, for papers by Hans Bijl Breakdown of academic impact, for papers by Elmer Yu